Åge Nærdal, Cand. Pharm. was the CEO of GlaxoSmithKline AS for 13 years. Åge is a visionary and energetic leader believing in empowerment of talented people to deliver high performance. Åge has 35 years experience in the pharmaceutical industry, most of these in leadership positions. While at GSK Norway, as a professional big-pharma leader, he worked closely with government authorities, including delivering vaccines for pandemic preparedness for the Swine Flu epidemic of 2009/10. Since 2015, Åge has served as an advisor to the pharmaceutical industry, including as an associate partner at First House. He served as a consultant for Coalition for Epidemic Preparedness Innovation (CEPI) from January 2017 to March 2020., Åge joined Norvax (formerly ECAM Norway) as CEO in October, 2020. He lives in Arendal with his family and is a proud grandfather of two young boys.